T. Rowe Price US Blue Chip Eq I1 USD

Performance History30/04/2024
Growth of 1,000 (EUR)
T. Rowe Price US Blue Chip Eq I1 USD
Fund----13.9
+/-Cat----4.2
+/-Idx----3.5
 
Key Stats
NAV
03/05/2024
 USD 14.44
Day Change 1.73%
Morningstar Category™ US Large-Cap Growth Equity
ISIN LU2594029303
Fund Size (Mil)
02/05/2024
 USD 717.79
Share Class Size (Mil)
02/05/2024
 USD 0.01
Max Initial Charge -
Ongoing Charge
01/02/2024
  0.58%
Investment Objective: T. Rowe Price US Blue Chip Eq I1 USD
To increase the value of its shares, over the long term, through growth in the value of its investments.
Returns
Trailing Returns (EUR)03/05/2024
YTD14.40
3 Years Annualised-
5 Years Annualised-
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
Paul Greene
01/10/2021
Inception Date
05/04/2023
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
S&P 500 (Net of 30% withhg tax)Morningstar US LM Brd Growth NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  T. Rowe Price US Blue Chip Eq I1 USD31/03/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks99.200.0099.20
Bonds0.240.000.24
Cash0.560.000.56
Other0.000.000.00
Top 5 Regions%
United States96.07
Eurozone1.82
Europe - ex Euro1.19
Asia - Developed0.70
United Kingdom0.23
Top 5 Sectors%
Technology41.51
Consumer Cyclical16.25
Healthcare13.64
Communication Services12.81
Financial Services10.15
Top 5 HoldingsSector%
Microsoft CorpTechnologyTechnology9.73
Amazon.com IncConsumer CyclicalConsumer Cyclical9.66
NVIDIA CorpTechnologyTechnology9.33
Apple IncTechnologyTechnology8.82
Alphabet Inc Class CCommunication ServicesCommunication Services4.75
T. Rowe Price US Blue Chip Eq I1 USD

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookie Settings        Disclosures